Nothing written yet for this company.
No news written yet.
| Period | 456160 | KOSDAQ | Difference |
|---|---|---|---|
| 1 week | -13.1% | -3.0% | -10.1% |
| 1 month | +3.5% | +4.2% | -0.7% |
| 3 months | -29.1% | -22.5% | -6.6% |
| 6 months | -54.8% | -16.9% | -38.0% |
| Year to date | -43.4% | -12.1% | -31.3% |
| 1 year | -23.5% | +1.0% | -24.5% |
Closed at 16% of the way from its 52-week low (₩22,950) to its 52-week high (₩118,800).
G2GBIO, Inc. makes prescription medicines in South Korea. It is listed on KOSDAQ, was founded in 2017, is based in North Chungcheong, and has revenue of under ten billion won.
| Sector | Biopharma | Employees | |
| Market | KOSDAQ | Founded | 2017 |
| Korean name | 지투지바이오 | Head office | North Chungcheong |
| Symbol | Last Price |
|---|---|
| 003850Boryung Corporation | ₩9,040 +1.6% |
| 950260Ingenia Therapeutics Inc.(reg.s) | ₩15,580 -1.5% |
| 085660Chabiotech Co., Ltd. | ₩8,090 +2.1% |
| 476060Onconic Therapeutics, Inc. | ₩16,440 -3.9% |
| 041960Komipharm International Co., Ltd. | ₩9,710 +3.5% |
| 317450Myungin Pharm | ₩44,650 +0.0% |
| 001060JW Pharmaceutical | ₩27,500 +1.3% |
| 019170Shinpoong Pharmaceutical Co., Ltd. | ₩10,010 -0.9% |
| 358570GI Innovation, Inc. | ₩8,090 +6.2% |
| 086900Medy-Tox, Inc. | ₩69,600 +0.4% |